
TY  - JOUR
TI  - GENOMICS, GENETIC BASIS OF DISEASE AND HLA/T CELL RECOGNITION
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_11.x
DO  - doi:10.1111/j.1479-8077.2006.00199_11.x
SP  - A66
EP  - A68
PY  - 2006
ER  - 

TY  - JOUR
TI  - INFECTION-RELATED RHEUMATIC DISEASES
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_14.x
DO  - doi:10.1111/j.1479-8077.2006.00199_14.x
SP  - A80
EP  - A83
PY  - 2006
ER  - 

TY  - JOUR
TI  - MISCELLANEOUS RHEUMATIC DISEASES
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_16.x
DO  - doi:10.1111/j.1479-8077.2006.00199_16.x
SP  - A90
EP  - A99
PY  - 2006
ER  - 

TY  - JOUR
TI  - OSTEOPOROSIS – CLINICAL ASPECTS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_20.x
DO  - doi:10.1111/j.1479-8077.2006.00199_20.x
SP  - A125
EP  - A142
PY  - 2006
ER  - 

TY  - JOUR
TI  - SPONDYLOARTHROPATHIES INCLUDING PSORIATIC ARTHRITIS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_28.x
DO  - doi:10.1111/j.1479-8077.2006.00199_28.x
SP  - A234
EP  - A247
PY  - 2006
ER  - 

TY  - JOUR
TI  - BACK PAIN
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_3.x
DO  - doi:10.1111/j.1479-8077.2006.00199_3.x
SP  - A26
EP  - A31
PY  - 2006
ER  - 

TY  - JOUR
TI  - BONE DISEASES OTHER THAN OSTEOPOROSIS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 0219-0494
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_4.x
DO  - doi:10.1111/j.1479-8077.2006.00199_4.x
SP  - A31
EP  - A33
PY  - 2006
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Research and Practice in Thrombosis and Haemostasis
JA  - Res Pract Thromb Haemost
VL  - 1
IS  - S1
SN  - 2475-0328
UR  - https://doi.org/10.1002/rth2.12012
DO  - doi:10.1002/rth2.12012
SP  - 1
EP  - 1451
PY  - 2017
ER  - 

TY  - JOUR
AU  - de Boer, J.
AU  - Meester, J. De
AU  - Smits, J.M.A.
AU  - Groenewoud, A. F.
AU  - Bok, A.
AU  - van der Velde, O.
AU  - Doxiadis, I.I.N.
AU  - Persijn, G.G.
TI  - Eurotransplant randomized multicenter kidney graft preservation study comparing HTK with UW and Euro–Collins
JO  - Transplant International
VL  - 12
IS  - 6
SN  - 0934-0874
UR  - https://doi.org/10.1111/j.1432-2277.1999.tb00773.x
DO  - doi:10.1111/j.1432-2277.1999.tb00773.x
SP  - 447
EP  - 453
KW  - Kidney transplantation
KW  - Initial non-function
KW  - Graft survival
KW  - UW Euro-Collins HTK
PY  - 1999
AB  - Abstract The aim was to evaluate the effect of HTK compared to UW and Euro?Collins (EC) on the initial graft function and long term graft survival in two prospective randomized studies. Only kidneys from heart-beating, kidney-only or kidney + heart donors were eligible for entry. Initial non-function (INF) was defined as the absence of life-sustaining renal function, requiring dialysis treatment on two or more occasions, during the first week after transplantation. To evaluate the contribution of the preservation solutions on INF in relation to other factors, a multivariate, 2-step logistic regression model was used. Randomization was performed between July 1990 and September 1992. The UW-HTK study comprised 342 donors and 611 transplants (UW: 168 donors and 297 transplants, HTK: 174 donors and 314 transplants). In the EC-HTK study 317 donors and 569 transplants were included (EC: 155 donors and 277 transplants, HTK: 162 donors and 292 transplants). INF occurred in 33 % of either HTK-(n = 105) or UW-(n= 99) preserved kidneys (P = NS), and in 29% of the HTK-(n= 85) and in 43% of the EC-(n= 119) preserved kidneys (P = 0.001). Multivariate analysis showed no significant influence of the preservation solution on the incidence of INF in the UW-HTK study, but factors contributing to INF were donor age, cause of death, retransplantation, and cold ischemic period. The EC-HTK study showed a significantly higher risk of INF, using EC as preservation, in addition to cold ischemic period and donor quality. The 3-year graft survival of HTK-preserved kidneys was 73 %, compared to 68 % for UW?preserved kidneys in the UW-HTK study (P = NS); while the 3-year graft survival of HTK preserved kidneys was 70 % compared to 67 % for EC-preserved kidneys in the EC-HTK study (P = NS). We can conclude that HTK is comparable to UW in its preservative abilities, using kidneys from heart-beating kidney-only donors, whereas EC as renal preservation solution should be avoided.
ER  - 

TY  - JOUR
TI  - Poster Session
JO  - Internal Medicine Journal
VL  - 39
IS  - s2
SN  - 1444-0903
UR  - https://doi.org/10.1111/j.1445-5994.2009.01952.x
DO  - doi:10.1111/j.1445-5994.2009.01952.x
SP  - A52
EP  - A77
PY  - 2009
ER  - 

TY  - JOUR
TI  - 2013 Annual Meeting of the American Society for Bone and Mineral Research Baltimore, MD October 4–7, 2013
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 28
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.2201
DO  - doi:10.1002/jbmr.2201
SP  - S1
EP  - S1
PY  - 2013
AB  - ABSTRACT Searchable abstracts may be found at http://www.asbmr.org/education/abstracts
ER  - 

TY  - JOUR
TI  - Guidelines on the diagnosis and management of AL amyloidosis
JO  - British Journal of Haematology
VL  - 125
IS  - 6
SN  - 0007-1048
UR  - https://doi.org/10.1111/j.1365-2141.2004.04970.x
DO  - doi:10.1111/j.1365-2141.2004.04970.x
SP  - 681
EP  - 700
KW  - AL amyloidosis
KW  - treatment
KW  - diagnosis
KW  - chemotherapy
KW  - stem cell transplantation
PY  - 2004
ER  - 

C7  - pp. 296-300
TI  - Joint Pain
SN  - 9781119244035
UR  - https://doi.org/10.1002/9781119578055.ch57
DO  - doi:10.1002/9781119578055.ch57
SP  - 296-300
KW  - crystal arthropathy
KW  - gastrointestinal infections
KW  - general practitioner
KW  - genito-urinary infections
KW  - joint pain
KW  - reactive arthritis
KW  - septic arthritis
PY  - 2004
AB  - Summary This chapter explores how to approach joint pain from a rheumatological perspective. It presents the case examples of an on-call SHO bleeped to review a 60 year old lady with a hot, swollen, painful right wrist and a 55 year old lady referred to the Rheumatologist by the general practitioner with a two week history of painful, swollen left wrist joint. Reactive arthritis is often seen following gastrointestinal and genito-urinary infections with specific micro-organisms. Pre-existing rheumatological disease increases the risk of septic arthritis and although the leflunomide was stopped it has a long half-life conferring an immunosuppressed state. Erythema of the skin overlying the affected joint raises the probability of either septic arthritis or crystal arthropathy. Variability in disease presentation and disease evolution over time constantly revise SQs. Paying attention to the SQs in flux ensures that are consciously considering other possibilities.
ER  - 

TY  - JOUR
TI  - METABOLIC AND CRYSTAL ARTHROPATHIES
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 9781119244035
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_15.x
DO  - doi:10.1111/j.1479-8077.2006.00199_15.x
SP  - A83
EP  - A90
PY  - 2006
ER  - 

TY  - JOUR
TI  - OSTEOARTHRITIS – CLINICAL ASPECTS
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 9781119244035
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_19.x
DO  - doi:10.1111/j.1479-8077.2006.00199_19.x
SP  - A108
EP  - A125
PY  - 2006
ER  - 

TY  - JOUR
TI  - ANTI-PHOSPHOLIPID SYNDROME
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 9781119244035
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_2.x
DO  - doi:10.1111/j.1479-8077.2006.00199_2.x
SP  - A25
EP  - A26
PY  - 2006
ER  - 

TY  - JOUR
TI  - PAEDIATRIC RHEUMATOLOGY
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 9781119244035
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_22.x
DO  - doi:10.1111/j.1479-8077.2006.00199_22.x
SP  - A159
EP  - A167
PY  - 2006
ER  - 

TY  - JOUR
TI  - RHEUMATOID ARTHRITIS – TREATMENT
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 9781119244035
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_24.x
DO  - doi:10.1111/j.1479-8077.2006.00199_24.x
SP  - A188
EP  - A210
PY  - 2006
ER  - 

TY  - JOUR
TI  - SJOGREN'S SYNDROME
JO  - APLAR Journal of Rheumatology
VL  - 9
IS  - s1
SN  - 9781119244035
UR  - https://doi.org/10.1111/j.1479-8077.2006.00199_27.x
DO  - doi:10.1111/j.1479-8077.2006.00199_27.x
SP  - A230
EP  - A234
PY  - 2006
ER  - 

TY  - JOUR
AU  - Aguero, Jaime
AU  - Almenar, Luis
AU  - Martínez-Dolz, Luis
AU  - Moro, Jose A
AU  - Rueda, Joaquin
AU  - Raso, Rafael
AU  - Chamorro, Carlos
AU  - Sanchez, Juan M
AU  - Salvador, Antonio
TI  - Influence of immunosuppressive regimens on short-term morbidity and mortality in heart transplantation
JO  - Clinical Transplantation
VL  - 22
IS  - 1
SN  - 9781119244035
UR  - https://doi.org/10.1111/j.1399-0012.2007.00751.x
DO  - doi:10.1111/j.1399-0012.2007.00751.x
SP  - 98
EP  - 106
KW  - complications
KW  - heart transplantation
KW  - immunosuppression
KW  - infection
KW  - rejection
KW  - survival
PY  - 2008
AB  - Abstract:? Background:? The goal of immunosuppressive therapy in heart transplantation is to maximize safety and efficacy while minimizing morbidity and mortality. We now have numerous drug combinations, but few have been compared with each other. Aim:? To compare various immunosuppressive regimens assessing morbidity and mortality at one yr. Methods:? A total of 351 patients transplanted between 1989 and 2005 were included and grouped by immunosuppressive regimen into group 1 (n?=?52): Muronomab (OKT3) 10?d, cyclosporine (CSA), azathioprine (AZA), steroids; group 2 (n?=?193): OKT3 seven d, CSA, AZA, steroids; group 3 (n?=?22): OKT3 seven d, CSA, mycophenolate mofetil (MMF), steroids; and group 4 (n?=?84): interleukin-2 antagonists (IL-2), CSA, MMF, steroids. Results:? The incidence of acute graft failure and treated rejection was similar between groups (17% and 78% respectively). We found a statistically significant difference in the incidence of infections (p?<?0.001), renal dysfunction (p?=?0.011) and in diabetes mellitus (p?=?0.023). There were no differences in survival at 30?d (97%), but differences were found at one yr (p?=?0.011). The multivariate analysis showed a strong association between mortality and infection (p?=?0.001) and between survival and the group 4 regimen (p?<?0.001). Conclusion:? There are differences in survival at one yr of heart transplant patients depending on the immunosuppressive regimen used. The best combination was induction with IL-2 antagonists, followed by CSA, MMF and steroids.
ER  - 
